Natera, Inc.
A clinical genetics company that reads traces of DNA floating in the blood to detect cancer, screen pregnancies, and monitor transplanted organs — its best-known tests include Signatera for cancer recurrence, Panorama for prenatal screening, and Prospera for transplant rejection. It began in 2004 as Gene Security Network, born from a founder's personal loss when a relative's baby died days after birth with an undetected condition. The company later renamed itself Natera, a word meant to echo "birth," "nature," and "earth."
Granted 332.3K · Sold 412.7K
Granted 2.3K · Sold 153.0K
Granted 54.2K · Sold 77.1K
Granted 68.0K · Sold 81.0K
Granted 62.7K · Sold 29.6K
Granted 376.9K · Sold 431.8K
Granted 84.0K · Sold 69.6K
Granted 82.2K · Sold 90.1K
Granted 14.7K · Sold 12.8K
Granted 13.2K · Sold 11.1K
Granted 1.9K
Granted 2.2K · Sold 64.9K
Granted 256
Granted 6.2K · Sold 7.5K
Granted 2.2K
Granted 1.9K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Rabinowitz MatthewEXECUTIVE CHAIRMAN, Director · 67 transactions | -4.1% | 2.29M | 332.3K | — | 412.7K |
| Botha RoelofDirector · 23 transactions | -12.2% | 1.08M | 2.3K | — | 153.0K |
| Sheena JonathanDirector, CO-FOUNDER · 113 transactions | -8.4% | 288.4K | 54.2K | — | 77.1K |
| Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER · 35 transactions | +2.1% | 206.5K | 68.0K | — | 81.0K |
| Fesko JohnPRESIDENT, CHIEF BUS. OFFICER · 18 transactions | +21.6% | 185.8K | 62.7K | — | 29.6K |
| Chapman Steven LeonardCEO AND PRESIDENT, Director · 60 transactions | -16.1% | 139.7K | 376.9K | — | 431.8K |
| Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS · 60 transactions | +11.1% | 137.6K | 84.0K | — | 69.6K |
| Brophy Michael BurkesCHIEF FINANCIAL OFFICER · 42 transactions | -15.3% | 57.5K | 82.2K | — | 90.1K |
| Baynes Roy D.Director · 16 transactions | +9.9% | 20.1K | 14.7K | — | 12.8K |
| Marcus Gail BoxerDirector · 12 transactions | +13% | 7.9K | 13.2K | — | 11.1K |
| Bertagnolli MonicaDirector · 5 transactions | +35.4% | 6.9K | 1.9K | — | — |
| Rosenman HermDirector · 11 transactions | -91.5% | 5.8K | 2.2K | — | 64.9K |
| Williams Brinkley RuthDirector · 3 transactions | +4.9% | 5.5K | 256 | — | — |
| Chapman Rowan EDirector · 11 transactions | -20.2% | 4.8K | 6.2K | — | 7.5K |
| Rubin Eric HDirector · 3 transactions | — | 2.2K | 2.2K | — | — |
| Lynch Thomas J. Jr.Director · 1 transaction | — | 1.9K | 1.9K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last year: -1.44M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.